Skip to content
DraconiticResearch
Search Sources API
186,125 studies31 sourcesUpdated 12 min ago
Peer-reviewedCC BY-NCERJ Open Research

No detectable infectious agents in Langerhans cell histiocytosis with lung involvement

  • Maud Salmona
  • Amira Benattia
  • Véronique Meignin
  • Valentine Marie Ferré
  • Fanélie Jouenne
  • Gwenaël Lorillon
  • Jerôme Le Goff
  • Samia Mourah
  • Abdellatif Tazi
Open at sourceDOICite

Abstract

Extract Langerhans cell histiocytosis (LCH) is a rare neoplastic disease of unknown aetiology driven by various somatic mutations in the mitogen-activated protein kinase (MAPK) pathway [1]. LCH is highly heterogeneous and may affect virtually any organ [2]. Lung involvement is frequently observed in adult LCH patients, almost exclusively in young smokers of both sexes [3].

Related

  1. Adult-onset Langerhans cell histiocytosis in an elderly female with cutaneous and nodal involvement: A case report
    Pei-Yun Ho, Hsingjin-Eugene Liu, Ying-Yi Chiang
    Dermatologica SinicaPeer-reviewedCC BY-NC-SAFull textPhysiologyDOAJ
  2. Extensive vulvar and perianal langerhans cell histiocytosis with clinical improvement during low-dose thalidomide and topical therapy: a case report
    Pan Zou, Xiao Mei Zhu
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Langerhans Cell Histiocytosis of the Vulva: A Pediatric Case.
    Marina Romero Navarrete, María Elisa Vega Memije, Sabrina Escandón Pérez +3
    Dermatology practical & conceptualPeer-reviewedCC BY-NCFull textPhysiologyEurope PMC
  4. Langerhans Cell Histiocytosis Involving the Hypothalamic–Pituitary System Accompanied by Adipsic Diabetes Insipidus and Multiple Anterior Pituitary Hormone Deficiencies: A Case Report
    Masakazu Uejima, Yukako Kurematsu, Kuniaki Ozaki +5
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0Full textPhysiologyCrossrefEurope PMC
  5. Multisystem Langerhans cell histiocytosis with hypothyroidism and sclerosing cholangitis: a case report and review of the literature.
    Jinhong Yu, Xiaoyan Liu, Xia Yu +2
    Journal of medical case reportsPeer-reviewedCC BY-NC-NDFull textPhysiologyEurope PMCPMC

Cite

BibTeXRIS
BibTeX
@article{salmona2026detectable,
  title = {{No detectable infectious agents in Langerhans cell histiocytosis with lung involvement}},
  author = {Maud Salmona and Amira Benattia and Véronique Meignin and Valentine Marie Ferré and Fanélie Jouenne and Gwenaël Lorillon and Jerôme Le Goff and Samia Mourah and Abdellatif Tazi},
  journal = {ERJ Open Research},
  year = {2026},
  month = jul,
  doi = {10.1183/23120541.01689-2025},
  url = {https://hal.science/hal-05782789v1},
  note = {CC BY-NC},
}
RIS
TY  - JOUR
TI  - No detectable infectious agents in Langerhans cell histiocytosis with lung involvement
AU  - Maud Salmona
AU  - Amira Benattia
AU  - Véronique Meignin
AU  - Valentine Marie Ferré
AU  - Fanélie Jouenne
AU  - Gwenaël Lorillon
AU  - Jerôme Le Goff
AU  - Samia Mourah
AU  - Abdellatif Tazi
PY  - 2026
DA  - 2026/07/16
JO  - ERJ Open Research
DO  - 10.1183/23120541.01689-2025
UR  - https://hal.science/hal-05782789v1
AB  - Extract Langerhans cell histiocytosis (LCH) is a rare neoplastic disease of unknown aetiology driven by various somatic mutations in the mitogen-activated protein kinase (MAPK) pathway [1]. LCH is highly heterogeneous and may affect virtually any organ [2]. Lung involvement is frequently observed in adult LCH patients, almost exclusively in young smokers of both sexes [3].
SN  - 2312-0541
ER  -